Abraham G. Hartzema, Pharm.D. and Ph.D., a professor and eminent scholar pharmaceutical outcomes research and policy, has been appointed for a three-year term as advisor to the newly established Institute for Health Economics Research Institute at the Sun Yat-Sen University School of Pharmaceutical Sciences. Sun Yat-Sen University is one of the top ranked universities in China. It is a comprehensive multidisciplinary university with an enrollment of over 82,000 students, with 1,208 students in the pharmaceutical sciences, including 98 Ph.D. and 337 MSc students.